Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation

被引:14
作者
Thiele, I
Kvasnicka, HM
Beelen, DW
Pilgram, B
Rose, A
Leder, LD
Schaefer, UW
机构
[1] Univ Cologne, Inst Pathol, D-50924 Cologne, Germany
[2] Univ Essen Gesamthsch, Dept Bone Marrow Transplant, Essen, Germany
关键词
erythropoiesis; macrophages; myelofibrosis; bone marrow biopsy; bone marrow transplantation; CML;
D O I
10.1038/sj.leu.2401838
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A clinicopathological study was conducted on 351 bone marrow trephine biopsies derived from 124 patients with chronic myeloid leukemia (CML) at standardized endpoints before and after allogeneic bone marrow transplantation (BMT). The purpose was to investigate quantitative changes of the nucleated erythroid precursor cell population and other associated features such as resident bone marrow macrophages and myelofibrosis and to elucidate their relevance on engraftment parameters. Monoclonal antibodies were applied for the identification of erythroid precursors and the labeling of mature macrophages; argyrophilic (reticulin-collagen) fibers were demonstrated by a silver impregnation technique. Following morphometric analysis of the pregraft bone marrow specimens statistical evaluation was in line with an adverse correlation between early to moderate reticulin fibrosis and amount of erythropoiesis. Moreover, a significant relationship was calculable between numbers of erythroid precursors and CD68(+) macrophages. After myelo-ablative therapy and BMT a pronounced decrease in cellularity and in the quantity of erythropoiesis was found. Comparable with the pregraft samples, a significant association between erythroid precursors and macrophages could be determined in the regenerating donor bone marrow. A pretransplant relevant reduction of the red cell lineage and a manifest (reticulin) myelofibrosis indicating an advanced stage of disease were accompanied by a significant delay to reach transfusion independence. This result was further supported by comparable findings in trephine biopsies performed in the early post-transplant period (second month after BMT). Corresponding examinations revealed an enhancement of fiber density and a decrease in erythropoiesis in those patients who did not conform with the usually accepted criteria for successful engraftment. In conclusion, compelling evidence has been produced that a significantly reduced amount of erythroid precursors, which is usually associated with myelofibrosis in the pretransplant bone marrow, exerts an impairment to undisturbed hematopoietic reconstitution. Moreover, a close spatial and numerical relationship between the erythroid lineage and resident (mature) macrophages is observable, in particular in the state of regeneration after BMT.
引用
收藏
页码:1378 / 1385
页数:8
相关论文
共 42 条
[1]  
APPELBAUM FR, 1995, SEMIN ONCOL, V22, P405
[2]  
BAUERMEISTER DE, 1971, AM J CLIN PATHOL, V56, P24
[3]   PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME [J].
BEELEN, DW ;
GRAEVEN, U ;
ELMAAGACLI, AH ;
NIEDERLE, N ;
KLOKE, O ;
OPALKA, B ;
SCHAEFER, UW .
BLOOD, 1995, 85 (10) :2981-2990
[4]   ABNORMAL FUNCTION OF THE BONE-MARROW MICROENVIRONMENT IN CHRONIC MYELOGENOUS LEUKEMIA - ROLE OF MALIGNANT STROMAL MACROPHAGES [J].
BHATIA, R ;
MCGLAVE, PB ;
DEWALD, GW ;
BLAZAR, BR ;
VERFAILLIE, CM .
BLOOD, 1995, 85 (12) :3636-3645
[5]  
BRETONGORIUS J, 1991, BLOOD CELLS, V17, P127
[6]   THE IMPACT OF MEGAKARYOCYTE PROLIFERATION FOR THE EVOLUTION OF MYELOFIBROSIS - HISTOLOGICAL FOLLOW-UP-STUDY IN 186 PATIENTS WITH CHRONIC MYELOID-LEUKEMIA [J].
BUHR, T ;
CHORITZ, H ;
GEORGII, A .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1992, 420 (06) :473-478
[7]   Allografting for chronic myeloid leukaemia [J].
Clift, RA ;
Anasetti, C .
BAILLIERES CLINICAL HAEMATOLOGY, 1997, 10 (02) :319-336
[8]   Natural history and staging of chronic myelogenous leukaemia [J].
Cortes, J ;
Kantarjian, HM ;
Giralt, S ;
Talpaz, M .
BAILLIERES CLINICAL HAEMATOLOGY, 1997, 10 (02) :277-290
[9]  
DEKMEZIAN R, 1987, CANCER, V59, P1739, DOI 10.1002/1097-0142(19870515)59:10<1739::AID-CNCR2820591011>3.0.CO
[10]  
2-2